Five months later, it rolled out Fewer Hot Flashes, More Not Flashes as part of a national TV campaign to promote the drug. In a way, it makes sense that the campaign is airing a commercial during the Super Bowl given that Astellas has been football-focused in its advertising around Veozah.

“Pharma advertisers placed a much heavier emphasis on NFL this December, with games generating 211% more TV ad impressions compared to December 2022,” Cassandra Arora, iSpot’s chief marketing officer, said in a statement. “Prescription and over-the-counter brands alike also focused on expanding reach with Spanish-speaking audiences, contributing to a 113% year-over-year ad impressions increase on Univision.”

If there are three tentpoles likely to remain for pharma advertising in 2024, it’s live sports, daytime TV and news, according to Tyler Bobin, senior brand analyst at real-time ad tracker iSpot.tv.

For the first time since February, Vicks is back on top as the lead Rx and over-the-counter (OTC) brand for ad impressions, according to data released by iSpot.tv Monday morning.

In September, Dupixent again snagged the top spot in the list of Rx and over-the-counter brands, according to data from iSpot.tv. Its share of voice was at 5.17%, with 3 billion impressions in total.

Skyrizi broke Dupixent’s three-month streak as the top Rx and over-the-counter (OTC) brand, according to data released by iSpot.tv Thursday morning.

The Crohn’s disease, psoriasis and psoriatic arthritis treatment from Boehringer Ingelheim and AbbVie led the way with an impressions share of voice (SOV) of 4.04% as well as 2.4 billion impressions: in total.

Dupixent registered 3.2 billion impressions during the month and had an estimated national TV ad spend of $34.5 million, according data from iSpot.tv released Monday afternoon. The top network for impressions SOV for the drug was ABC, while the top program was World News Tonight With David Muir.

According to data from MediaRadar, Pfizer and Johnson & Johnson both spent more than $100 million on advertising in digital, print, and national TV in 2022. Notably, Pfizer also led the way with more than 175 million impressions and $9.5 million in TV commercial buys across games during the early part of the 2022 NFL season, according to data from iSpot.tv.